Cargando…

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome

OBJECTIVE: To analyze the clinical effect of nasal continuous positive airway pressure (CPAP) combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome (NRDS). METHODS: Eighty-two NRDS patients who received treatment from August 2017 to June 2019 in our hospital w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Jing, Xie, Haitao, Zhang, Yanping, Guo, Xiaohui, Cui, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260922/ https://www.ncbi.nlm.nih.gov/pubmed/32494249 http://dx.doi.org/10.12669/pjms.36.4.1963

Ejemplares similares

Clinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome
por: Zhang, Congmin, et al.
Publicado: (2017)

Early Surfactant Therapy With Nasal Continuous Positive Airway Pressure or Continued Mechanical Ventilation in Very Low Birth Weight Neonates With Respiratory Distress Syndrome
por: Najafian, Bita, et al.
Publicado: (2014)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates
por: Liu, Jinfeng, et al.
Publicado: (2017)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Efficacy and safety of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure ventilation in neonatal respiratory distress syndrome: a systematic review and meta-analysis
por: Liu, Hua, et al.
Publicado: (2022)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Noninvasive Positive Pressure Ventilation or Conventional Mechanical Ventilation for Neonatal Continuous Positive Airway Pressure Failure
por: Badiee, Zohreh, et al.
Publicado: (2014)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Continuous long-term prone position ventilation effects in pulmonary acute respiratory distress syndrome patients
por: Gorrasi, J, et al.
Publicado: (2007)

Pulmonary surfactant function in patients with acute lung injury/acute respiratory distress syndrome treated by mechanical ventilation
por: Miller, E, et al.
Publicado: (2005)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants
por: Gharehbaghi, Manizheh Mostafa, et al.
Publicado: (2019)

Noninvasive positive-pressure ventilation in acute respiratory distress syndrome: preliminary results
por: Principi, T, et al.
Publicado: (1999)

Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation—a randomized controlled trial
por: Gupta, Bhupendra Kumar, et al.
Publicado: (2020)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
por: Tarocco, Anna, et al.
Publicado: (2015)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

Efficacy of continuous positive airway pressure in neonates with respiratory distress syndrome: A protocol for systematic review and meta-analysis
por: Cao, Junyi, et al.
Publicado: (2021)

Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome
por: YIN, XIAOJUAN, et al.
Publicado: (2012)

No inhalation in combination with high frequency ventilation treatment in the treatment of neonatal severe respiratory failure
por: Guo, Xiaohui, et al.
Publicado: (2016)

Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets*
por: Rey-Santano, Carmen, et al.
Publicado: (2020)

Reduction in minute alveolar ventilation causes hypercapnia in ventilated neonates with respiratory distress
por: Zuiki, Masashi, et al.
Publicado: (2020)

Negative- versus positive-pressure ventilation in intubated patients with acute respiratory distress syndrome
por: Raymondos, Konstantinos, et al.
Publicado: (2012)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
por: Tarocco, Anna, et al.
Publicado: (2015)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial
por: Malakian, Arash, et al.
Publicado: (2021)

Management of Neonatal Respiratory Distress Syndrome Employing ACoRN Respiratory Sequence Protocol versus Early Nasal Continuous Positive Airway Pressure Protocol
por: Niknafs, Pedram, et al.
Publicado: (2014)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Nasal Continuous Positive Airway Pressure with Heliox in Preterm Infants with Respiratory Distress Syndrome
por: Mosalli, Rafat
Publicado: (2012)

Predictor Factors of Continuous Positive Airway Pressure Failure in Preterm Infants with Respiratory Distress
por: Permatahati, Winda Intan, et al.
Publicado: (2021)

In Vitro Performance of an Investigational Vibrating-Membrane Nebulizer with Surfactant under Simulated, Non-Invasive Neonatal Ventilation Conditions: Influence of Continuous Positive Airway Pressure Interface and Nebulizer Positioning on the Lung Dose
por: Bianco, Federico, et al.
Publicado: (2020)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
por: Logan, J Wells, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_tf8sp50dnjkkcvmflttrubvbmn